Ventricular expression of natriuretic peptides in Npr1-/- mice with cardiac hypertrophy and fibrosis

1  Department of Medicine, Christchurch School of Medicine, Christchurch, New Zealand; and 2  Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7525 Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are cardiac hormone...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2002-08, Vol.283 (2), p.H707-H714
Hauptverfasser: Ellmers, L. J, Knowles, J. W, Kim, H.-S, Smithies, O, Maeda, N, Cameron, V. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1  Department of Medicine, Christchurch School of Medicine, Christchurch, New Zealand; and 2  Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7525 Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are cardiac hormones that regulate blood pressure and volume, and exert their biological actions via the natriuretic peptide receptor-A gene ( Npr1 ). Mice lacking Npr1 ( Npr / ) have marked cardiac hypertrophy and fibrosis disproportionate to their increased blood pressure. This study examined the relationships between ANP and BNP gene expression, immunoreactivity and fibrosis in cardiac tissue, circulating ANP levels, and ANP and BNP mRNA during embryogenesis in Npr1 / mice. Disruption of the Npr1 signaling pathway resulted in augmented ANP and BNP gene and ANP protein expression in the cardiac ventricles, most pronounced for ANP mRNA in females [414 ± 57 in Npr1 / ng/mg and 124 ± 25 ng/mg in wild-type (WT) by Taqman assay, P  
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.00677.2001